NOVELION THERAPEUTICS Trademark

Trademark Overview

On Thursday, May 19, 2016, a trademark application was filed for NOVELION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the NOVELION THERAPEUTICS trademark a serial number of 87043469. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 26, 2024. This trademark is owned by Aegerion Pharmaceuticals, Inc.. The NOVELION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
novelion therapeutics

General Information

Serial Number87043469
Word MarkNOVELION THERAPEUTICS
Filing DateThursday, May 19, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 26, 2024
Registration Number5381456
Registration DateTuesday, January 16, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 26, 2024
Primary Code042
First Use Anywhere DateTuesday, November 29, 2016
First Use In Commerce DateTuesday, November 29, 2016

Trademark Owner History

Party NameNOVELION THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Wednesday, September 7, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 25, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 4, 2016ASSIGNED TO EXAMINER
Wednesday, September 7, 2016NON-FINAL ACTION WRITTEN
Wednesday, September 7, 2016NON-FINAL ACTION E-MAILED
Wednesday, February 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 1, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 28, 2017WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, March 14, 2017EXAMINERS AMENDMENT E-MAILED
Monday, March 13, 2017PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, March 14, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 14, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, March 14, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 14, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, November 14, 2017USE AMENDMENT FILED
Tuesday, March 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2017SOU EXTENSION 1 FILED
Tuesday, November 21, 2017SOU EXTENSION 1 GRANTED
Tuesday, December 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 16, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 16, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, July 26, 2024CANCELLED SEC. 8 (6-YR)
Wednesday, September 25, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, November 20, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 21, 2017STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 9, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 18, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

therapeutics novelion development research pharmaceutical